原發性中樞神經系統淋巴瘤一例診療分析_West China Medical Journal

Authors：

 李花 , 張霖 ,  鄒曉毅

四川大學華西醫院神經內科（成都 610041）;

Corresponding?author：

李花, Email: liyishenng@foxmail.com; 鄒曉毅, Email: xiaoyizou@163.com

Keywords：

原發性中樞神經系統淋巴瘤; 臨床特點; 治療

DOI：

10.7507/1002-0179.201600158

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李花, 張霖, 鄒曉毅. 原發性中樞神經系統淋巴瘤一例診療分析. West China Medical Journal, 2016, 31(3): 592-593. doi: 10.7507/1002-0179.201600158 Copy

1.	Basso K, Dalla-Favera R. BCL6:master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis[J]. Adv Immunol, 2010, 105(10) :193-210.
2.	Schlegel U, Jürgens A, Pels H. Primary central nervous system lymphomas (PCNSL):MRI response criteria revised[J]. Neurology, 2006, 66(8) :1287.
3.	Thompsett AR, Ellison DW, Stevenson FK, et al. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity[J]. Blood, 1999, 94(5) :1738-1746.
4.	Deckert M, Brunn A, Montesinos-Rongen M, et al. Primary lymphoma of the central nervous system:a diagnostic challenge[J]. Hematol Oncol, 2014, 32(2) :57-67.
5.	Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma[J]. Nat Rev Neurol, 2013, 9(6) :317-327.
6.	Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma[J]. Surv Ophthalmol, 2014, 59(5) :503-516.
7.	Roth P, Martus P, Kiewe P, et al. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial[J]. Neurology, 2012, 79(9) :890-896.
8.	Holdhoff M, Ambady P, Abdelaziz A, et al. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma[J]. Neurology, 2014, 83(3) :235-239.
9.	Bierman PJ. Surgery for primary central nervous system lymphoma:is it time for reevaluation?[J]. Oncology (Williston Park), 2014, 28(7) :632-637.
10.	Prica A, Chan K, Cheung M. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma:a cost-effectiveness analysis[J]. Neuro Oncol, 2014, 16(10) :1384-1391.

1. Basso K, Dalla-Favera R. BCL6:master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis[J]. Adv Immunol, 2010, 105(10) :193-210.
2. Schlegel U, Jürgens A, Pels H. Primary central nervous system lymphomas (PCNSL):MRI response criteria revised[J]. Neurology, 2006, 66(8) :1287.
3. Thompsett AR, Ellison DW, Stevenson FK, et al. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity[J]. Blood, 1999, 94(5) :1738-1746.
4. Deckert M, Brunn A, Montesinos-Rongen M, et al. Primary lymphoma of the central nervous system:a diagnostic challenge[J]. Hematol Oncol, 2014, 32(2) :57-67.
5. Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma[J]. Nat Rev Neurol, 2013, 9(6) :317-327.
6. Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma[J]. Surv Ophthalmol, 2014, 59(5) :503-516.
7. Roth P, Martus P, Kiewe P, et al. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial[J]. Neurology, 2012, 79(9) :890-896.
8. Holdhoff M, Ambady P, Abdelaziz A, et al. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma[J]. Neurology, 2014, 83(3) :235-239.
9. Bierman PJ. Surgery for primary central nervous system lymphoma:is it time for reevaluation?[J]. Oncology (Williston Park), 2014, 28(7) :632-637.
10. Prica A, Chan K, Cheung M. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma:a cost-effectiveness analysis[J]. Neuro Oncol, 2014, 16(10) :1384-1391.

Previous Article
乳腺癌和真實世界研究
Next Article
內科成功保守治療經口內鏡食管肌切開術后并發雙肺壓縮約35%氣胸患者一例

West China Medical Journal

原發性中樞神經系統淋巴瘤一例診療分析

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content